Literature DB >> 21999126

Prognostic significance of tumor budding in gastrointestinal tumors.

Bruno Märkl1, Hans M Arnholdt.   

Abstract

Tumor budding describes the presence of single tumor cells or small tumor cell clusters at the invasion front of carcinomas. It is currently thought to be the result of epithelial-mesenchymal transformation. Tumor budding can be appreciated histologically during routine evaluation of malignant polyps or surgical specimens of malignant tumors. Many studies have been published assessing cancers in all locations from the esophagus to the rectum, almost always reporting similar results. This seems especially remarkable as a generally accepted definition of how budding must be evaluated is still lacking. Regardless of the location, tumor budding generally is associated with nodal metastases and aggressive behavior, and it is mostly independent from other adverse factors. While the prognostic value of tumor budding is evident, especially in stage II colorectal cancers, it still has no therapeutic implications. This is owing to the heterogeneity of the performed studies and the lack of oncological studies, which are urgently needed.

Entities:  

Mesh:

Year:  2011        PMID: 21999126     DOI: 10.1586/era.11.156

Source DB:  PubMed          Journal:  Expert Rev Anticancer Ther        ISSN: 1473-7140            Impact factor:   4.512


  7 in total

1.  Interobserver variability in the H&E-based assessment of tumor budding in pT3/4 colon cancer: does it affect the prognostic relevance?

Authors:  Benedikt Martin; Eva Schäfer; Elzbieta Jakubowicz; Patrick Mayr; Regina Ihringer; Matthias Anthuber; Gerhard Schenkirsch; Tina Schaller; Bruno Märkl
Journal:  Virchows Arch       Date:  2018-04-06       Impact factor: 4.064

Review 2.  [Pathology of early stage cancer of the gastrointestinal tract : Definition, principles and diagnosis].

Authors:  B Märkl; B Martin
Journal:  Chirurg       Date:  2018-05       Impact factor: 0.955

Review 3.  Metastatic cancer stem cells: from the concept to therapeutics.

Authors:  Wen-Ting Liao; Ya-Ping Ye; Yong-Jian Deng; Xiu-Wu Bian; Yan-Qing Ding
Journal:  Am J Stem Cells       Date:  2014-09-05

4.  A new simple morphology-based risk score is prognostic in stage I/II colon cancers.

Authors:  Bruno Märkl; Maximilian Märkl; Tina Schaller; Patrick Mayr; Gerhard Schenkirsch; Bernadette Kriening; Matthias Anthuber
Journal:  Cancer Med       Date:  2016-05-11       Impact factor: 4.452

5.  Circulating cytokeratin-positive cells and tumor budding in colorectal cancer.

Authors:  Bruno Märkl; Narjes Wilhelms; Matthias Anthuber; Gerhard Schenkirsch; Günter Schlimok; Daniel Oruzio
Journal:  World J Clin Oncol       Date:  2016-12-10

6.  Potential key roles of tumour budding: a representative malignant pathological feature of non-small cell lung cancer and a sensitive indicator of prognosis.

Authors:  Li Qian; Jianguo Zhang; Shumin Lu; Xin He; Jia Feng; Jiahai Shi; Yifei Liu
Journal:  BMJ Open       Date:  2022-03-31       Impact factor: 2.692

7.  Tumor Budding, uPA, and PAI-1 in Colorectal Cancer: Update of a Prospective Study.

Authors:  Bruno Märkl; Jochen Hardt; Simon Franz; Tina Schaller; Gerhard Schenkirsch; Bernadette Kriening; Reinhard Hoffmann; Stefan Rüth
Journal:  Gastroenterol Res Pract       Date:  2017-02-12       Impact factor: 2.260

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.